Back to
FEDERATED HERMES, INC.
MYGN30 quarters
Position history for
FEDERATED HERMES, INC.'s holdings in MYRIAD GENETICS INC
Yes. Federated Hermes holds 1,570,314 shares of MYGN (Myriad Genetics), worth $9M, as of its Q2 2026 13F filing. It reduced the position by 405,852 shares (-20.5%) from Q1 2026. Federated Hermes has held MYGN since Q1 2020, across 26 quarterly 13F filings.
Current Value
$9M
Current Shares
1.6M
Total Value Change
+$5.4M
Total Shares Change
+1.4M
Quarter-by-Quarter History
Other major holders of MYGN: BlackRock, Inc., BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC